Literature DB >> 21678026

Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection.

Kang-jie Chen1, Lin Zhou, Hai-yang Xie, Taki-eldin Ahmed, Xiao-wen Feng, Shu-sen Zheng.   

Abstract

Tumor-infiltrating lymphocytes (TILs) represent the host immune response to cancer. CD8(+) cytotoxic T cells (CTLs) have a central role in the elimination of tumors, while regulatory T cells (Tregs) can suppress the immune reaction. The aim of this study was to investigate the prognostic value of TILs, especially Tregs and CTLs, in hepatocellular carcinoma (HCC) patients after resection. CD3(+), CD4(+), CD8(+), and FoxP3(+) TILs were assessed by immunohistochemistry in tumor tissue from 141 randomly selected HCC patients. Prognostic effects of low- or high-density TIL subsets were evaluated by Kaplan-Meier and Cox regression analysis using the median values as cutoff. The density of intratumoral Tregs (P = 0.040) and peritumoral CTLs (P = 0.004) were an independent factor for overall survival (OS), but not for disease-free survival (DFS). The density of CD3(+) and CD4(+) TILs, and the prevalence of Tregs and CTLs were associated with neither OS nor DFS. The presence of low intratumoral Tregs with high intratumoral CTLs was a negative independent prognostic factor for OS (P = 0.001), while that of low intratumoral Tregs and low peritumoral CTLs independently correlated with improved DFS (P = 0.008). Moreover, the combined analysis of Tregs and CTLs displayed better prognostic performances than any of them alone. Additionally, higher density of intratumoral Tregs correlated with both the presence of liver cirrhosis (P = 0.025) and increased tumor size (P = 0.050). Tregs within tumor environment are promising prognostic parameters for HCC patients, and their combination with CTLs can predict prognosis more effectively.

Entities:  

Mesh:

Year:  2011        PMID: 21678026     DOI: 10.1007/s12032-011-0006-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  24 in total

1.  Combination of peritumoral mast cells and T-regulatory cells predicts prognosis of hepatocellular carcinoma.

Authors:  Min-Jie Ju; Shuang-Jian Qiu; Qiang Gao; Jia Fan; Ming-Yan Cai; Yi-Wei Li; Zhao-You Tang
Journal:  Cancer Sci       Date:  2009-05-04       Impact factor: 6.716

2.  Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

Authors:  Nobuyoshi Hiraoka; Kaoru Onozato; Tomoo Kosuge; Setsuo Hirohashi
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

3.  Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma.

Authors:  Gerhard G Grabenbauer; Godehard Lahmer; Luitpold Distel; Gerald Niedobitek
Journal:  Clin Cancer Res       Date:  2006-06-01       Impact factor: 12.531

4.  Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.

Authors:  Tomás Alvaro; Marylène Lejeune; Ma Teresa Salvadó; Ramón Bosch; Juan F García; Joaquín Jaén; Alison H Banham; Giovanna Roncador; Carlos Montalbán; Miguel A Piris
Journal:  Clin Cancer Res       Date:  2005-02-15       Impact factor: 12.531

5.  Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

Authors:  Qiang Gao; Shuang-Jian Qiu; Jia Fan; Jian Zhou; Xiao-Ying Wang; Yong-Sheng Xiao; Yang Xu; Yi-Wei Li; Zhao-You Tang
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

6.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

7.  FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.

Authors:  Noritoshi Kobayashi; Nobuyoshi Hiraoka; Wataru Yamagami; Hidenori Ojima; Yae Kanai; Tomoo Kosuge; Atsushi Nakajima; Setsuo Hirohashi
Journal:  Clin Cancer Res       Date:  2007-02-01       Impact factor: 12.531

8.  High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma.

Authors:  Xiao-Dong Zhu; Ju-Bo Zhang; Peng-Yuan Zhuang; Hong-Guang Zhu; Wei Zhang; Yu-Quan Xiong; Wei-Zhong Wu; Lu Wang; Zhao-You Tang; Hui-Chuan Sun
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544

9.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

Authors:  Lin Zhang; Jose R Conejo-Garcia; Dionyssios Katsaros; Phyllis A Gimotty; Marco Massobrio; Giorgia Regnani; Antonis Makrigiannakis; Heidi Gray; Katia Schlienger; Michael N Liebman; Stephen C Rubin; George Coukos
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

10.  FOXP3 defines regulatory T cells in human tumor and autoimmune disease.

Authors:  Ilona Kryczek; Rebecca Liu; Guobin Wang; Ke Wu; Xiaogong Shu; Wojciech Szeliga; Linhua Vatan; Emily Finlayson; Emina Huang; Diane Simeone; Bruce Redman; Theodore H Welling; Alfred Chang; Weiping Zou
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

View more
  34 in total

1.  Correlation analysis of peripheral blood T cell subgroups, immunoglobulin and prognosis of early hepatocellular carcinoma after hepatectomy.

Authors:  Yi-Qun Che; Lin Feng; Wei-Qi Rong; Di Shen; Qian Wang; Lin Yang; Jun Qi; Chang-Zhi Huang
Journal:  Int J Clin Exp Med       Date:  2014-11-15

2.  Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.

Authors:  Ze-Xiao Lin; Dan-Yun Ruan; Yang Li; Dong-Hao Wu; Xiao-Kun Ma; Jie Chen; Zhan-Hong Chen; Xing Li; Tian-Tian Wang; Qu Lin; Jing-Yun Wen; Xiang-Yuan Wu
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

3.  Prediction of local recurrence in cervical cancer by a Cox model comprised of lymph node status, lymph-vascular space invasion, and intratumoral Th17 cell-infiltration.

Authors:  Qing Yu; Xiang-Ming Lou; Yan He
Journal:  Med Oncol       Date:  2013-12-06       Impact factor: 3.064

4.  Immunoprofiling for prognostic assessment of colon cancer: a novel complement to ultrastaging.

Authors:  Simon Lavotshkin; John R Jalas; Hitoe Torisu-Itakura; Junko Ozao-Choy; Ji Hey Lee; Myung Shin Sim; Alexander Stojadinovic; Zev Wainberg; Carlo B Bifulco; Bernard A Fox; Anton J Bilchik
Journal:  J Gastrointest Surg       Date:  2015-03-26       Impact factor: 3.452

Review 5.  Role of innate immunity in the development of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 6.  Host response in tumor diagnosis and prognosis: importance of immunologists and pathologists alliance.

Authors:  Olivera J Finn
Journal:  Exp Mol Pathol       Date:  2012-10-23       Impact factor: 3.362

7.  Intraperitoneal perfusion of cytokine-induced killer cells with local hyperthermia for advanced hepatocellular carcinoma.

Authors:  Xiao-Pu Wang; Meng Xu; Hong-Fei Gao; Jian-Fu Zhao; Ke-Cheng Xu
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

8.  Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses.

Authors:  Valerie Chew; Liyun Lai; Lu Pan; Chun Jye Lim; Juntao Li; Raymond Ong; Camillus Chua; Jing Yao Leong; Kiat Hon Lim; Han Chong Toh; Ser Yee Lee; Chung Yip Chan; Brian K P Goh; Alexander Chung; Pierce K H Chow; Salvatore Albani
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-03       Impact factor: 11.205

Review 9.  Influence of human immune cells on cancer: studies at the University of Colorado.

Authors:  Tullia C Bruno; Jena D French; Kimberly R Jordan; Oscar Ramirez; Trisha R Sippel; Virginia F Borges; Bryan R Haugen; Martin D McCarter; Allen Waziri; Jill E Slansky
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

10.  Effect of cytokine-induced killer cells on immune function in patients with lung cancer.

Authors:  Yanyan Pan; Yuanyuan Wu; Jun Ji; Hongjiao Cai; Heshuang Wang; Yifan Jiang; Limin Sang; Jin Yang; Yanyan Gao; Ying Liu; Liangwei Yin; L I Zhang
Journal:  Oncol Lett       Date:  2016-02-29       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.